Haichen Wang Selected Research

Closed Head Injuries

9/2022	Prophylactic treatment with CN-105 improves functional outcomes in a murine model of closed head injury.
1/2021	Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice.
6/2020	Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells.
8/2013	Lacosamide improves outcome in a murine model of traumatic brain injury.
7/2007	Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
4/2007	Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway.
2/2006	Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model.
1/2006	Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.
3/2005	A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haichen Wang Research Topics

Disease

20	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 12/2003
12	Brain Injuries (Brain Injury) 01/2021 - 03/2005
10	Cerebral Hemorrhage 10/2021 - 01/2010
9	Closed Head Injuries 09/2022 - 03/2005
9	Inflammation (Inflammations) 01/2021 - 12/2003
7	Brain Edema (Cerebral Edema) 10/2018 - 01/2006
6	Neuroinflammatory Diseases 01/2021 - 03/2013
6	Hematoma 01/2016 - 02/2011
4	Neoplasms (Cancer) 01/2022 - 11/2011
4	Hemorrhage 07/2014 - 02/2011
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2006 - 09/2005
3	Craniocerebral Trauma (Head Injury) 01/2021 - 04/2007
3	Ischemic Stroke 01/2020 - 02/2011
3	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 11/2011
3	Brain Ischemia (Cerebral Ischemia) 03/2013 - 09/2005
2	Myocardial Infarction 04/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2022 - 08/2019
2	Infections 11/2021 - 05/2016
2	Aortic Dissection 01/2021 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2005
2	Infarction (Infarctions) 01/2017 - 03/2013
2	Ischemia 02/2014 - 03/2013
2	Stroke (Strokes) 01/2014 - 02/2011
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2012 - 02/2011
2	Encephalitis (Encephalitis, Rasmussen) 03/2005 - 12/2003
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Bacteriuria 01/2022
1	Hemolysis 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hemorrhagic Stroke 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Diabetes Mellitus 01/2020
1	Heart Failure 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Overweight 01/2020
1	Reperfusion Injury 11/2019
1	Heart Valve Diseases (Valvular Heart Disease) 11/2019
1	Bacteremia 01/2019
1	Diarrhea 01/2019
1	Neutropenia 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Neoplasm Metastasis (Metastasis) 05/2016

Drug/Important Bio-Agent (IBA)

12	Apolipoproteins E (ApoE)IBA 09/2022 - 12/2003
9	ApolipoproteinsIBA 09/2022 - 03/2005
7	apolipoprotein E mimetic peptide CN-105IBA 10/2021 - 10/2016
6	Peptides (Polypeptides)IBA 09/2022 - 12/2003
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2012
3	Neuroprotective AgentsIBA 09/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2005
3	fluoro jadeIBA 01/2021 - 02/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2007
3	COG1410IBA 03/2013 - 07/2007
3	PorphyrinsIBA 11/2012 - 02/2006
3	Simvastatin (Zocor)FDA LinkGeneric 05/2012 - 09/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2016
2	Carbapenems (Carbapenem Antibiotics)IBA 11/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 08/2013
2	CytokinesIBA 01/2016 - 07/2007
2	Collagenases (Collagenase)FDA Link 07/2014 - 01/2010
2	Levetiracetam (Keppra)FDA LinkGeneric 08/2013 - 01/2006
2	Protein Isoforms (Isoforms)IBA 03/2013 - 01/2006
2	MetalloporphyrinsIBA 11/2012 - 11/2011
2	Apolipoprotein E4IBA 01/2006 - 03/2005
1	AcidsIBA 09/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022
1	Kallikreins (Kallikrein)IBA 01/2022
1	SilverIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	AgarIBA 01/2022
1	Fosfomycin FDA Link 11/2021
1	Minichromosome Maintenance ProteinsIBA 01/2021
1	ArgonIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	NitrogenIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 06/2020
1	HDL-triglycerideIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	CreatinineIBA 01/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 11/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2019
1	InflammasomesIBA 10/2018
1	Tight Junction ProteinsIBA 10/2018
1	LipidsIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	4,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amineIBA 01/2018
1	Gonadal HormonesIBA 05/2017
1	Angiotensin IIIBA 01/2017
1	triphenyltetrazoliumIBA 01/2017
1	Pharmaceutical PreparationsIBA 05/2016
1	Matrix Metalloproteinases (MMPs)IBA 05/2016
1	tetrandrineIBA 05/2016

Therapy/Procedure

6	Therapeutics 04/2022 - 11/2010
1	Radiotherapy 01/2022
1	Transplantation 01/2022
1	Patient Readmission 01/2020
1	Lasers (Laser) 01/2018